Domonkos Pál

ORCID: 0000-0002-0226-0004
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Proteoglycans and glycosaminoglycans research
  • Glycosylation and Glycoproteins Research
  • Fibroblast Growth Factor Research
  • Extracellular vesicles in disease
  • Polysaccharides Composition and Applications
  • Prostate Cancer Treatment and Research
  • RNA Interference and Gene Delivery
  • MicroRNA in disease regulation
  • Advanced Fiber Laser Technologies

Semmelweis University
2022-2024

HUN-REN Research Centre for Natural Sciences
2021-2024

Institute of Organic Chemistry
2024

Hungarian Research Network
2021

Research Network (United States)
2021

Abstract Extracellular vesicles (EVs) are critical mediators of intercellular communication and hold promise as biomarkers therapeutic targets in cancer, but their molecular alterations remain poorly understood. Protein glycosylation is a frequent post-translational modification; however, most EV studies focus only on proteomics, while mapping changes proteins still underrepresented. To address this shortcoming, we analyzed the proteomic, N -glycoproteomic, chondroitin/dermatan sulfate...

10.1101/2025.03.13.643059 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2025-03-15

Lung cancer is one of the most commonly diagnosed types. Studying molecular changes that occur in lung important to understand tumor formation and identify new therapeutic targets early markers disease decrease mortality. Glycosaminoglycan chains play roles various signaling events microenvironment. Therefore, we have determined quantity sulfation characteristics chondroitin sulfate heparan formalin-fixed paraffin-embedded human tissue samples belonging different types as well adjacent...

10.3390/ijms24087050 article EN International Journal of Molecular Sciences 2023-04-11

Chronic liver diseases have both high incidence and mortality rates; therefore, a deeper understanding of the underlying molecular mechanisms is essential. We determined content sulfation pattern chondroitin sulfate (CS) heparan (HS) in human hepatocellular carcinoma cirrhotic tissues, considering etiology diseases. A variety pathological conditions such as alcoholic disease, hepatitis B C virus infections, primary sclerosing cholangitis were studied. Major differences observed total...

10.1007/s00216-022-04025-3 article EN cc-by Analytical and Bioanalytical Chemistry 2022-03-28

Abstract Heparan sulphates (HSs), a specific class of glycosaminoglycans (GAGs), are important participants cellular signalling. Analytical characterization GAGs requires complex sample preparation workflow. Although detailed stability and recovery study is available for the chondroitin sulphate GAG class, literature concerning HS incomplete in this regard. Therefore, our aim was to systematically investigate various parameters that could potentially influence samples when performing...

10.1002/elps.202400091 article EN cc-by-nc Electrophoresis 2024-08-21

Abstract Chondroitin sulfate (CS) is a widely studied class of glycosaminoglycans, responsible for diverse biological functions. Structural analysis CS generally based on disaccharide analysis. Sample preparation key analytical issue in this case. However, detailed study the stability and recovery CS-derived species has been lacking so far. We have found that solvent exchange, general, vacuum evaporation (SpeedVac) much preferable than lyophilization. Moreover, case aqueous solutions, higher...

10.1007/s00216-021-03152-7 article EN cc-by Analytical and Bioanalytical Chemistry 2021-01-27

Prostate cancer is one of the most frequent types among men. Several biomarkers and risk assessment methods are already available; however, enhancing their selectivity sensitivity still necessary. For improving therapeutic decisions, both basic clinical research studies ongoing for a better understanding underlying molecular mechanisms. The enzymatic digests heparan sulfate (HS) chondroitin (CS) chains were investigated in tissue samples taken from patients with prostate (PCa) benign...

10.3390/cancers14194867 article EN Cancers 2022-10-05
Coming Soon ...